- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2011
- Public Summary Document (PSD) July 2011 PBAC Meeting - PDF
Sunitinib malate – July 2011
Sunitinib malate, capsules, 12.5 mg, 25 mg and 50 mg (base), Sutent® - July 2011
Last updated
11 November 2011
